Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.
Gynecol Oncol. 2019 Feb 18;:
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
Nat Commun. 2019 Feb 04;10(1):558
J Clin Pathol. 2019 Feb;72(2):102-111
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analyses.
Int J Gynecol Cancer. 2019 Jan 18;:
Eur J Endocrinol. 2018 Dec 01;:
Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.
Genome Med. 2018 Oct 31;10(1):81
Histopathology. 2018 Oct 16;:
A clinical and molecular Phase II trial of oral ENMD-2076 in ovarian clear cell carcinoma (OCCC): A study of the Princess Margaret Phase II Consortium.
Clin Cancer Res. 2018 Aug 14;:
Regulatory T cells in ovarian cancer are characterized by a highly activated phenotype distinct from that in melanoma.
Clin Cancer Res. 2018 Jul 31;:
Brain Sci. 2018 Jun 09;8(6):